Enliven Therapeutics
ELVN
#3538
Rank
A$6.09 B
Marketcap
A$83.21
Share price
-1.08%
Change (1 day)
199.31%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Enliven Therapeutics CIK: 0001672619

Thumbnail Enliven Therapeutics 10-K Annual Report 2025

10-K Annual Report 2025

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Enliven Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)